EP3406719A1 — Calcineurin b homologous protein 1 inhibitors and therapeutic and non-therapeutic uses thereof
Assigned to Universitaet zu Koeln · Expires 2018-11-28 · 7y expired
What this patent protects
The invention relates to an inhibitor of Calcineurin B Homologous Protein 1 (CHP1) for use in a method for the treatment or prevention of a patient suffering from or being at risk of developing a disorder associated with a pathological calcium homeostasis, impaired vesicular traf…
USPTO Abstract
The invention relates to an inhibitor of Calcineurin B Homologous Protein 1 (CHP1) for use in a method for the treatment or prevention of a patient suffering from or being at risk of developing a disorder associated with a pathological calcium homeostasis, impaired vesicular trafficking and/or disturbed neuronal and/or neuromuscular synaptic function.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.